Close

Improving the lives of patients by combating metastatic cancer

We create innovative tools that provide deeper insights into cancer behaviour

The Vortex mission is to be the innovation leader in CTC capture technology that improves therapeutic decisions and saves lives

A New Window into Cancer Biology

Circulating tumour cells (CTCs) provide a real-time window into cancer biology; offering critical insights into the molecular and cellular mechanisms that drive the disease.

There is a major shift toward liquid biopsy in how cancer is studied and treated. As an innovation leader in Circulating Tumour Cell (CTC) capture technology, we’re helping researchers isolate and study circulating tumour cells — a key step in developing the next generation of anti-metastatic cancer therapies. Our advanced system offers a powerful tool to support more targeted and effective treatment development.

Circulating Tumour Cells Offer a Key Advantage

Circulating tumour cells (CTCs) provide real time insights into tumours progression. The analysis of CTCs can help to guide treatment decisions and improve patient outcomes.

Unlike circulating tumour DNA (ctDNA), CTCs are intact, viable cancer cells that provide real-time insights into tumour progression, evolution and treatment resistance. Their ability to deliver both molecular and functional information makes them invaluable for precision oncology.

VTX-1 Liquid Biopsy System

The Vortex VTX-1 Liquid Biopsy System simplifies and automates the isolation and collection of clinically relevant, viable CTCs directly from whole blood.

qui1000_liquid_biopsy_for_cancer_care_modern_image_ba6679f4-fca9-4b70-8e4f-9f08591c8054

Vortex Biosciences Poised to Revolutionize Liquid Biopsy with Advanced CTC Isolation

London, UK – August 17, 2021 – Vortex Biosciences is making significant strides in the rapidly evolving liquid biopsy landscape, with its cutting-edge VTX-1 platform gaining recognition
Read More
scientist-laboratory-microscope

Vortex Technology Utilised in Breakthrough Prenatal Diagnosis Research

https://www.prweb.com/releases/vortex-biosciences-announces-publication-in-prenatal-diagnosis-journal-using-its-technology-for-enrichment-of-circulating-trophoblasts-from-maternal-blood-liqu
Read More
qui1000_Single_blood_sample_vial_or_test_tube_prominently_featu_c8d47a11-6466-4442-b562-59c0f596821f

Vortex Technology Enables Comprehensive Lung Cancer Monitoring from a Single Blood Sample

https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.572895/full Edinburgh, UK – October 8, 2020 – A new study demonstrates the potential of Vortex Biosciences’
Read More